Swahili
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

Giant Cell Arteritis and PET Scan (GAPS) Study

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala
Ingia / Ingia
Kiungo kimehifadhiwa kwenye clipboard
HaliImekamilika
Wadhamini
Royal North Shore Hospital

Maneno muhimu

Kikemikali

Giant cell arteritis (GCA) is a medium to large vessel vasculitis with a predilection for the superficial cranial and intrathoracic arteries. Diagnosing the condition and predicting which patients will develop large vessel complications remains a challenge. There are limitations with temporal artery biopsy, magnetic resonance angiography and ultrasound of temporal arteries and American College of Rheumatology classification criteria.
Positron emission tomography (PET) has been shown to be a useful modality in detecting inflammation in large intra-thoracic vessels but previously has not been able to accurately detect FDG uptake in the superficial cranial arteries due to poor spatial resolution. Newer scanners can perform finer cuts of the head and can detect uptake in these arteries.
This study has three main components:
1. Cross sectional study assessing the accuracy of PET uptake in the superficial cranial and intrathoracic arteries of suspected GCA patients for the diagnosis of GCA
2. Cohort study assessing the prognostic implication of FDG aortic uptake on aortic diameter at 24 months
3. Cohort study assessing the Th1 and Th17 cytokine profile in patients with and without FDG PET uptake at 0, 6 and 24 months

Tarehe

Imethibitishwa Mwisho: 02/29/2020
Iliyowasilishwa Kwanza: 05/08/2016
Uandikishaji uliokadiriwa Uliwasilishwa: 05/10/2016
Iliyotumwa Kwanza: 05/12/2016
Sasisho la Mwisho Liliwasilishwa: 03/09/2020
Sasisho la Mwisho Lilichapishwa: 03/11/2020
Tarehe halisi ya kuanza kwa masomo: 05/14/2016
Tarehe ya Kukamilisha Msingi iliyokadiriwa: 01/27/2020
Tarehe ya Kukamilisha Utafiti: 01/27/2020

Hali au ugonjwa

Giant Cell Arteritis

Awamu

-

Vikundi vya Arm

MkonoUingiliaji / matibabu
Suspected GCA (GCA final diagnosis)
Suspected GCA (alternative final diagnosis)

Vigezo vya Kustahiki

Zama zinazostahiki Kujifunza 50 Years Kwa 50 Years
Jinsia Inastahiki KujifunzaAll
Njia ya sampuliProbability Sample
Hupokea Wajitolea wa AfyaNdio
Vigezo

Inclusion Criteria:

- Rheumatologist, neurologist or ophthalmologist suspect diagnosis of GCA

- Age > 50

- Meet at least 2 of 1990 American College of Rheumatology classification criteria for GCA

1. Age >= 50

2. ESR >= 50

3. New onset localised headache

4. Temporal artery abnormality (tenderness or decreased pulsation)

5. Positive biopsy (will not be available at time of enrolment)

Exclusion Criteria:

- Corticosteroid therapy for > 72 hours before first PET scan

- Prolonged corticosteroid therapy (> 1 week) for another indication in past 6 months

- History of vasculitis or connective tissue disease

- Active malignancy

Matokeo

Hatua za Matokeo ya Msingi

1. Diagnostic accuracy of FDG uptake in the superficial cranial or intrathoracic arteries for the diagnosis of temporal artery biopsy proven GCA amongst patients with suspected GCA [Baseline]

Hatua za Matokeo ya Sekondari

1. Difference in aortic diameter at 24 months between patients with and without PET scan aortic uptake at time 0. [24 months]

2. Difference in Th1 and Th17 axis cytokines in patients with and without thoracic large vessel PET uptake at 0, 6 and 24 months [24 months]

3. Prevalence of varicella zoster virus antigen and DNA in temporal artery biopsy GCA specimens [24 months]

4. Prevalence of acute varicella zoster IgM serology positivity in biopsy confirmed GCA patients [24 months]

5. Difference in combined vascular events between GCA patients with and without thoracic large vessel PET uptake at 0, 6 and 24 months [24 months]

6. Difference in temporal artery histology between GCA patients with and without thoracic large vessel PET uptake at 0 months [Baseline]

7. Difference in temporal artery histology between GCA patients with and without temporal artery PET uptake at 0 months [Baseline]

Jiunge na ukurasa
wetu wa facebook

Hifadhidata kamili ya mimea ya dawa inayoungwa mkono na sayansi

  • Inafanya kazi katika lugha 55
  • Uponyaji wa mitishamba unaungwa mkono na sayansi
  • Kutambua mimea kwa picha
  • Ramani ya GPS inayoshirikiana
  • Soma machapisho ya kisayansi yanayohusiana na utafutaji wako
  • Tafuta mimea ya dawa na athari zao
  • Panga maslahi yako na fanya tarehe ya utafiti wa habari, majaribio ya kliniki na ruhusu

Andika dalili au ugonjwa na usome juu ya mimea ambayo inaweza kusaidia, chapa mimea na uone magonjwa na dalili ambazo hutumiwa dhidi yake.
* Habari zote zinategemea utafiti wa kisayansi uliochapishwa

Google Play badgeApp Store badge